We are live on ! Find out more
HR

Howe & Rusling Portfolio holdings

AUM $1.53B
1-Year Est. Return 21.45%
This Fund
S&P 500
This Quarter Est. Return
-3.12%
1 Year Est. Return
+21.45%
3 Year Est. Return
+66.11%
5 Year Est. Return
+83.74%
10 Year Est. Return
+259.21%
AUM
$847M
AUM Growth
-$46.4M
Cap. Flow
-$12.6M
Cap. Flow %
-1.49%
Top 10 Hldgs %
28.15%
Holding
348
New
16
Increased
131
Reduced
120
Closed
35

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$8.3M
2
IUSG icon
iShares Core S&P US Growth ETF
IUSG
+$5.26M
3
TJX icon
TJX Companies
TJX
+$2.9M
4
AMT icon
American Tower
AMT
+$2.79M
5
DTE icon
DTE Energy
DTE
+$1.54M

Sector Composition

Rank Sector Weight
1 Technology 15.6%
2 Healthcare 10.94%
3 Financials 10.77%
4 Consumer Staples 8.64%
5 Energy 6.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRTX icon
76
Vertex Pharmaceuticals
VRTX
$123B
$2.69M 0.32%
7,744
-267
-3% -$93.4K
IQLT icon
77
iShares MSCI Intl Quality Factor ETF
IQLT
$14.1B
$2.69M 0.32%
80,016
+7,693
+11% +$270K
CMCSA icon
78
Comcast
CMCSA
$87.8B
$2.68M 0.32%
60,493
+469
+0.8% +$20.9K
IEFA icon
79
iShares Core MSCI EAFE ETF
IEFA
$194B
$2.66M 0.31%
41,329
+2,303
+6% +$154K
LHX icon
80
L3Harris
LHX
$53.3B
$2.46M 0.29%
14,121
-192
-1% -$35.3K
VEU icon
81
Vanguard FTSE All-World ex-US ETF
VEU
$68B
$2.43M 0.29%
46,814
+2,347
+5% +$127K
CRWD icon
82
CrowdStrike
CRWD
$214B
$2.38M 0.28%
56,960
-9,560
-14% -$372K
CTVA icon
83
Corteva
CTVA
$52.5B
$2.35M 0.28%
45,994
-1,970
-4% -$104K
AMAT icon
84
Applied Materials
AMAT
$424B
$2.31M 0.27%
16,702
+5
+0% +$717
NSC icon
85
Norfolk Southern
NSC
$76.8B
$2.28M 0.27%
11,597
-44
-0.4% -$9.51K
PBJ icon
86
Invesco Food & Beverage ETF
PBJ
$108M
$2.23M 0.26%
52,692
+475
+0.9% +$21.2K
BMRN icon
87
BioMarin Pharmaceuticals
BMRN
$11.6B
$2.18M 0.26%
24,600
-11,013
-31% -$980K
ADBE icon
88
Adobe
ADBE
$103B
$2.17M 0.26%
4,246
-6
-0.1% -$3.15K
SWKS icon
89
Skyworks Solutions
SWKS
$10.1B
$2.12M 0.25%
21,495
ASML icon
90
ASML
ASML
$645B
$2.07M 0.24%
3,523
+1,751
+99% +$1.16M
PFE icon
91
Pfizer
PFE
$147B
$2.07M 0.24%
62,425
-4,537
-7% -$160K
DGRO icon
92
iShares Core Dividend Growth ETF
DGRO
$43.4B
$2.02M 0.24%
40,690
+8,840
+28% +$458K
ZS icon
93
Zscaler
ZS
$26.1B
$1.93M 0.23%
12,417
-2,373
-16% -$356K
MGV icon
94
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.4B
$1.93M 0.23%
19,042
-3,431
-15% -$360K
MRK icon
95
Merck
MRK
$317B
$1.88M 0.22%
18,306
-356
-2% -$38.4K
OEF icon
96
iShares S&P 100 ETF
OEF
$20.4B
$1.84M 0.22%
9,155
-92
-1% -$19.2K
BNL icon
97
Broadstone Net Lease
BNL
$4.07B
$1.83M 0.22%
127,665
-17,424
-12% -$279K
SHEL icon
98
Shell
SHEL
$243B
$1.55M 0.18%
24,132
-262
-1% -$16.3K
SCHB icon
99
Schwab US Broad Market ETF
SCHB
$44.6B
$1.54M 0.18%
92,463
+10,320
+13% +$179K
MCD icon
100
McDonald's
MCD
$195B
$1.53M 0.18%
5,808
-37
-0.6% -$10.6K

Similar funds

Howe & Rusling's Q3 2023 Portfolio in Review

As of Q3 2023, Howe & Rusling held 348 positions worth $847M, down 5.2% from $894M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Howe & Rusling's Q3 2023 filing shows 16 new, 131 increased, 120 reduced and 35 closed positions. Its largest new stake was Vanguard Mortgage-Backed Securities ETF: 5,672 shares worth $248K. The largest sale was Cigna, an estimated $6.78M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

  • Howe & Rusling's largest Q3 2023 buy was Vanguard Mortgage-Backed Securities ETF: 5,672 shares worth $248K.
  • Howe & Rusling added most to AbbVie in Q3 2023, an estimated $8.3M increase.
  • Howe & Rusling's biggest Q3 2023 reduction was Cigna, cutting an estimated $6.78M.
  • Howe & Rusling fully exited Live Nation Entertainment in Q3 2023, selling an estimated $1.71M.
  • Howe & Rusling's ten largest holdings make up 28% of its $847M portfolio in Q3 2023.
  • Howe & Rusling opened 16 new positions and closed 35 in Q3 2023.
  • Howe & Rusling's portfolio value fell 5.2% quarter-over-quarter to $847M.

Based on Howe & Rusling's 13F filing for Q3 2023, filed 9 Nov 2023.